Announcements Trials
Browse Landscape

Phase

Phase NA 52Phase 2 10Phase 1 5Phase 4 4Phase EARLY_PHASE1 3Phase 3 3Phase 2/3 3Phase 1/2 1

Status

Completed 5Terminated 3Recruiting 3Unknown 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 74Other hematologic neoplasm 32Lymphoid 27Genitourinary 27Thoracic 24Gynecologic 24Head & Neck 19Breast 17Plasma cell 9Dermatologic 9CNS 8Tumor-Agnostic 5Myeloid 5Endocrine 5Sarcoma 3Other solid neoplasm 3Other 3NET 3Classical hematology 3

Conditions

Obesity 2Progesterone Resistance 1Polycystic Ovary Syndrome 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Dyspnea 1

Interventions

semaglutide 1Metformin 1Letrozole 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Recruiting × Other × Clear all
NCT06336642 2026-03-10

Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology

M.D. Anderson Cancer Center

Phase 2/3 Recruiting
150 enrolled
Other

Dyspnea

NCT06379113 2025-08-11

GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients

Fudan University

Phase 2/3 Recruiting
29 enrolled
GynecologicOther

Progesterone Resistance, Endometrial Hyperplasia, Obesity, Endometrial Neoplasms

NCT06896981 2025-04-02

Semaglutide in Women With Polycystic Ovary Syndrome and Obesity

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Phase 2/3 Recruiting
30 enrolled
Other

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡